The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction.
Makaleler > Tam Makale · 2019
Yazarlar: C Paitazoglou, R Özdemir, R Pfister, MW Bergmann, J Bartunek, T Kilic, A Lauten, A Schmeisser, Mehdi ZOGHİ, S Anker, H Sievert, F Mahfoud
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2019, cilt 15, ss 403-410